00:28:39 EDT Mon 21 Apr 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

C:INNO - InnoCan Pharma Corporation - Common Shares - https://innocanpharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
INNO - C  1.00.17·0.1831.00.18    0.33  0.15Apr 17Apr 0715 min RT 2¢
CSE - C1.00.17·0.1831.00.18    0.33  0.15Apr 1715 min

Recent Trades - All 0 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-04-07 18:35C:INNO0.16News ReleaseInnocan files application for Chinese CBD tech patent
2025-03-31 06:02C:INNO0.205SEDAR MD & ASEDAR MD & A
2025-03-31 06:01C:INNO0.205SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-03-07 17:15C:INNO0.20News ReleaseInnocan Pharma closes $1-million (U.S.) offering
2025-02-27 20:16C:INNO0.20News ReleaseInnocan Pharma arranges $1M (U.S.) debenture placement
2024-12-31 17:13C:INNO0.21News ReleaseInnocan Pharma closes $635,444 private placement
2024-12-19 20:15C:INNO0.195News ReleaseInnocan Pharma arranges $700,000 financing
2024-12-12 19:30C:INNO0.21News ReleaseInnocan Pharma releases annual R&D report
2024-11-20 16:53C:INNO0.21SEDAR Interim MD & ASEDAR Interim MD & A
2024-11-20 16:47C:INNO0.21SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-11-11 16:44C:INNO0.23News ReleaseInnocan to focus on LPT-CBD, cancels CLX project
2024-10-16 16:01C:INNO0.215News ReleaseInnocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience
2024-10-11 16:38C:INNO0.22News ReleaseInnocan reviews study on CBD therapy for dogs
2024-09-03 18:57C:INNO0.24News ReleaseInnocan receives FDA OK for preinvestigational new drug
2024-08-29 16:31C:INNO0.24News ReleaseInnocan Pharma closes $1.1-million private placement
2024-08-22 17:18C:INNO0.24News ReleaseInnocan Pharma's BI Sky Global gets FDA's okay
2024-08-12 17:13C:INNO0.22SEDAR Interim MD & ASEDAR Interim MD & A
2024-08-12 17:07C:INNO0.22SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-08-12 16:50C:INNO0.22News ReleaseInnocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million
2024-07-26 16:20C:INNO0.25News ReleaseInnocan receives INAD number for LPT-CBD